Cohance Lifesciences Ltd
Cohance Lifesciences's GHG Emissions Data Preview
In 2025, Cohance Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Cohance Lifesciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Cohance Lifesciences’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cohance Lifesciences’s data sources below and access millions more through our Disclosure Search.
Insights into Cohance Lifesciences's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Cohance Lifesciences amounted to 57,228 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Cohance Lifesciences decreased by 10.75%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Cohance Lifesciences's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Cohance Lifesciences's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Cohance Lifesciences were 31,818 metric tons of CO₂ equivalent (tCO₂e). a
Has Cohance Lifesciences reduced its Scope 1 emissions over time?
Since 2022, Cohance Lifesciences's Scope 1 emissions have decreased by 33.01%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Cohance Lifesciences's Scope 1 emissions decreased by 22.74%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Cohance Lifesciences's Scope 2 emissions?
In 2025, Cohance Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 25,410 tCO₂e without specifying the calculation method. a
Has Cohance Lifesciences reduced its Scope 2 emissions over time?
Since 2022, Cohance Lifesciences's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 28.35%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2024), Cohance Lifesciences's Scope 2 emissions (Unspecified Calculation Method) rose by 10.76% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Cohance Lifesciences use for Scope 2 reporting?
In 2025, Cohance Lifesciences reported its Scope 2 emissions using an unspecified methodology. a
Cohance Lifesciences's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Cohance Lifesciences's Value Chain Emissions
In 2025, Cohance Lifesciences reported 54,050.7 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Cohance Lifesciences includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Cohance Lifesciences's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Cohance Lifesciences's Scope 3 emissions?
In 2025, Cohance Lifesciences reported total Scope 3 emissions of 54,050.7 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2024), Cohance Lifesciences's Scope 3 emissions remained relatively stable, indicating that Cohance Lifesciences 's emissions have plateaued with no significant change in its value chain footprint. a
Insights into Cohance Lifesciences’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Cohance Lifesciences reported Scope 1 greenhouse gas (GHG) emissions of 31,818 tCO₂e and total revenues of USD 140 millions. This translates into an emissions intensity of 227 tCO₂e per millions USD. a
Cohance Lifesciences's Scope 1 Emissions Intensity Compared to Peers
How does Cohance Lifesciences's GHG emissions intensity compare to its peers?
In 2025, Cohance Lifesciences reported a Scope 1 emissions intensity of 227 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Cohance Lifesciences rank on GHG emissions intensity within its industry?
In 2025, Cohance Lifesciences ranked 22 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Cohance Lifesciences among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into Cohance Lifesciences's Total Carbon Footprint
In 2025, Cohance Lifesciences reported a total carbon footprint of 111,278.7 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 2.64% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to Cohance Lifesciences's total carbon footprint was Scope 3 emissions, accounting for 48.57% of the company's total carbon footprint, followed by Scope 1 emissions at 28.59%. a